Abstract

Chronic obstructive pulmonary disease (COPD) is a destructive inflammatory disease and the genes expressed within the lung are crucial to its pathophysiology. We have determined the RNAseq transcriptome of bronchial brush cells from 312 stringently defined ex-smoker patients. Compared to healthy controls there were for males 40 differentially expressed genes (DEGs) and 73 DEGs for females with only 26 genes shared. The gene ontology (GO) term “response to bacterium” was shared, with several different DEGs contributing in males and females. Strongly upregulated genes TCN1 and CYP1B1 were unique to males and females, respectively. For male emphysema (E)-dominant and airway disease (A)-dominant COPD (defined by computed tomography) the term “response to stress” was found for both sub-phenotypes, but this included distinct up-regulated genes for the E-sub-phenotype (neutrophil-related CSF3R, CXCL1, MNDA) and for the A-sub-phenotype (macrophage-related KLF4, F3, CD36). In E-dominant disease, a cluster of mitochondria-encoded (MT) genes forms a signature, able to identify patients with emphysema features in a confirmation cohort. The MT-CO2 gene is upregulated transcriptionally in bronchial epithelial cells with the copy number essentially unchanged. Both MT-CO2 and the neutrophil chemoattractant CXCL1 are induced by reactive oxygen in bronchial epithelial cells. Of the female DEGs unique for E- and A-dominant COPD, 88% were detected in females only. In E-dominant disease we found a pronounced expression of mast cell-associated DEGs TPSB2, TPSAB1 and CPA3. The differential genes discovered in this study point towards involvement of different types of leukocytes in the E- and A-dominant COPD sub-phenotypes in males and females.

Details

Title
Gender specific airway gene expression in COPD sub-phenotypes supports a role of mitochondria and of different types of leukocytes
Author
Esteve-Codina, Anna 1 ; Hofer, Thomas P 2 ; Burggraf Dorothe 3 ; Heiss-Neumann, Marion S 3 ; Gesierich Wolfgang 3 ; Boland, Anne 4 ; Olaso, Robert 4 ; Marie-Therese, Bihoreau 4 ; Deleuze Jean-Francois 4 ; Moeller Winfried 5 ; Schmid, Otmar 5 ; Soler, Artigas María 1 ; Renner Kathrin 6 ; Hohlfeld, Jens M 7 ; Welte, Tobias 8 ; Fuehner, Thomas 8 ; Jerrentrup Lukas 9 ; Koczulla Andreas Rembert 9 ; Greulich Timm 9 ; Prasse Antje 7 ; Müller-Quernheim Joachim 10 ; Gupta, Sumit 11 ; Brightling, Christopher 11 ; Subramanian, Deepak R 12 ; Parr, David G 12 ; Kolsum Umme 13 ; Gupta, Vandana 13 ; Barta Imre 14 ; Döme Balázs 15 ; Strausz János 16 ; Stendardo Mariarita 17 ; Piattella Marco 17 ; Boschetto Piera 17 ; Korzybski Damian 18 ; Gorecka Dorota 18 ; Nowinski, Adam 18 ; Dabad Marc 1 ; Fernández-Callejo Marcos 1 ; Endesfelder, David 19 ; zu Castell Wolfgang 20 ; Hiemstra, Pieter S 21 ; Venge Per 22 ; Noessner Elfriede 23 ; Griebel Thasso 1 ; Heath, Simon 1 ; Singh, Dave 13 ; Gut Ivo 1 ; Ziegler-Heitbrock Loems 3 

 Barcelona Institute of Science and Technology (BIST), CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona, Spain (GRID:grid.473715.3) (ISNI:0000 0004 6475 7299); Universitat Pompeu Fabra (UPF), Barcelona, Spain (GRID:grid.5612.0) (ISNI:0000 0001 2172 2676) 
 Helmholtz Zentrum Muenchen and Asklepios-Klinik, EvA Study Center, Gauting, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525); Helmholtz Zentrum Muenchen, Immunoanalytics-Core Facility, Munich, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525) 
 Helmholtz Zentrum Muenchen and Asklepios-Klinik, EvA Study Center, Gauting, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525) 
 Université Paris-Saclay, Centre National de Recherche en Génomique Humaine (CNRGH), Institut de Biologie François Jacob, CEA, Evry, France (GRID:grid.460789.4) (ISNI:0000 0004 4910 6535) 
 Helmholtz Zentrum Muenchen, Institute for Lung Biology and Disease, Neuherberg-Munich, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525) 
 University Hospital Regensburg, Internal Medicine III, Regensburg, Germany (GRID:grid.411941.8) (ISNI:0000 0000 9194 7179) 
 Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany (GRID:grid.418009.4) (ISNI:0000 0000 9191 9864); Hannover Medical School, Department of Respiratory Medicine, Hannover, Germany (GRID:grid.10423.34) (ISNI:0000 0000 9529 9877); Member of the German Center for Lung Research (DZL), Hannover, Germany (GRID:grid.452624.3) 
 Hannover Medical School, Department of Respiratory Medicine, Hannover, Germany (GRID:grid.10423.34) (ISNI:0000 0000 9529 9877); Member of the German Center for Lung Research (DZL), Hannover, Germany (GRID:grid.452624.3) 
 Member of the German Center for Lung Research (DZL), Marburg, Germany (GRID:grid.452624.3); University Medical Center Giessen and Marburg, Philipps-University, Department of Medicine, Pulmonary and Critical Care Medicine, Marburg, Germany (GRID:grid.10253.35) (ISNI:0000 0004 1936 9756) 
10  University of Freiburg, Department of Pneumology, Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9) 
11  NIHR Leicester BRC, University of Leicester, Institute for Lung Health, Leicester, UK (GRID:grid.9918.9) (ISNI:0000 0004 1936 8411) 
12  University Hospitals Coventry and Warwickshire NHS Trust, Department of Respiratory Medicine, Coventry, UK (GRID:grid.15628.38) 
13  University of Manchester, University Hospital of South Manchester Foundations Trust, Medicines Evaluation Unit, Manchester, UK (GRID:grid.5379.8) (ISNI:0000000121662407) 
14  National Koranyi Institute for TB and Pulmonology, Department of Pathophysiology, Budapest, Hungary (GRID:grid.419688.a) (ISNI:0000 0004 0442 8063) 
15  National Koranyi Institute for TB and Pulmonology, Department of Tumorbiology, Budapest, Hungary (GRID:grid.419688.a) (ISNI:0000 0004 0442 8063) 
16  National Koranyi Institute for TB and Pulmonology, Department of Pneumology, Budapest, Hungary (GRID:grid.419688.a) (ISNI:0000 0004 0442 8063) 
17  University of Ferrara and Ferrara City Hospital, Department of Medical Sciences, Ferrara, Italy (GRID:grid.8484.0) (ISNI:0000 0004 1757 2064) 
18  National Institute of Tuberculosis and Lung Diseases, 2nd Department of Respiratory Medicine, Warsaw, Poland (GRID:grid.419019.4) (ISNI:0000 0001 0831 3165) 
19  Helmholtz Zentrum Muenchen, ICT Department, Munich, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525) 
20  Helmholtz Zentrum Muenchen, Department Strategy & Digitalization, Munich, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525); Technical University of Munich, Faculty of Mathematics, Munich, Germany (GRID:grid.6936.a) (ISNI:0000000123222966) 
21  Leiden University Medical Center, Department of Pulmonology, Leiden, The Netherlands (GRID:grid.10419.3d) (ISNI:0000000089452978) 
22  University of Uppsala, Department of Medical Sciences, Uppsala, Sweden (GRID:grid.8993.b) (ISNI:0000 0004 1936 9457) 
23  Immunoanalytics-Tissue Control of Immunocytes, Helmholtz Zentrum Muenchen, Munich, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2542530009
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.